Prognostic significance of TMEM16A, PPFIA1, and FADD expression in invasive ductal carcinoma of the breast

World Journal of Surgical Oncology

Volumn 12, Issue 1, 2014, Pages

  Choi, Eun J ^a   Yun, Jeong A ^a   Jabeen, Sahrish ^a   Jeon, Eun K ^a   Won, Hye S ^a   Ko, Yoon H ^a   Kim, Su Y ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Breast; Carcinoma; Ductal; FADD protein; PPFIA1 protein; TMEM16A protein

Indexed keywords

ESTROGEN RECEPTOR; FAS ASSOCIATED DEATH DOMAIN PROTEIN; PPFIA1 PROTEIN; PROGESTERONE RECEPTOR; PROTEIN; TMEM16A PROTEIN; UNCLASSIFIED DRUG; ANO1 PROTEIN, HUMAN; CHLORIDE CHANNEL; FADD PROTEIN, HUMAN; PPFIA1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PERINEURAL INVASION; PROTEIN EXPRESSION; BREAST TUMOR; CANCER GRADING; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; TUMOR RECURRENCE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHLORIDE CHANNELS; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84901032996     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-12-137     Document Type: Article

References (32)

1. Alberts B, Wilson JH, Hunt T. Molecular Biology of the Cell 2008, New York: Garland Science, 5.
2. Peters G, Fantl V, Smith R, Brookes S, Dickson C. Chromosome 11q13 markers and D-type cyclins in breast cancer. Breast Cancer Res Treat 1995, 33:125-135. 10.1007/BF00682720, 7749140.
3. Karlseder J, Zeillinger R, Schneeberger C, Czerwenka K, Speiser P, Kubista E, Birnbaum D, Gaudray P, Theillet C. Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chromosomes Cancer 1994, 9:42-48. 10.1002/gcc.2870090108, 7507699.
4. Gaffey MJ, Frierson HF, Williams ME. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations. Mod Pathol 1993, 6:654-659.
5. Shi ZZ, Jiang YY, Hao JJ, Zhang Y, Zhang TT, Shang L, Liu SG, Shi F, Wang MR. Identification of putative target genes for amplification within 11q13.2 and 3q27.1 in esophageal squamous cell carcinoma. Clin Transl Oncol 2013, Epub ahead of print.
6. Meredith SD, Levine PA, Burns JA, Gaffey MJ, Boyd JC, Weiss LM, Erickson NL, Williams ME. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis. Arch Otolaryngol Head Neck Surg 1995, 121:790-794. 10.1001/archotol.1995.01890070076016, 7598859.
7. Williams ME, Gaffey MJ, Weiss LM, Wilczynski SP, Schuuring E, Levine PA. Chromosome 11Q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1993, 119:1238-1243. 10.1001/archotol.1993.01880230084013, 8217084.
8. Jarmuz-Szymczak M, Pelinska K, Kostrzewska-Poczekaj M, Bembnista E, Giefing M, Brauze D, Szaumkessel M, Marszalek A, Janiszewska J, Kiwerska K, Bartochowska A, Grenman R, Szyfter W, Szyfter K. Heterogeneity of 11q13 region rearrangements in laryngeal squamous cell carcinoma analyzed by microarray platforms and fluorescence in situ hybridization. Mol Biol Rep 2013, 40:4161-4171. 10.1007/s11033-013-2496-4, 23652995.
9. Blessmann M, Al-Dam A, Hanken H, Assaf AT, Riecke B, Klatt J, Simon R, Sauter G, Heiland M, Kluwe L, Grobe A. Amplification of the PPFIA1 gene region on 11q13 in oral squamous cell carcinomas (OSCC). J Craniomaxillofac Surg 2013, 41:845-849. 10.1016/j.jcms.2013.01.040, 23453270.
10. Rosa-Rosa JM, Pita G, Gonzalez-Neira A, Milne RL, Fernandez V, Ruivenkamp C, van Asperen CJ, Devilee P, Benitez J. A 7 Mb region within 11q13 may contain a high penetrance gene for breast cancer. Breast Cancer Res Treat 2009, 118:151-159. 10.1007/s10549-009-0317-1, 19205878.
11. Gibcus JH, Menkema L, Mastik MF, Hermsen MA, de Bock GH, van Velthuysen ML, Takes RP, Kok K, Alvarez Marcos CA, van der Laan BF, van den Brekel MW, Langendijk JA, Kluin PM, van der Wal JE, Schuuring E. Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer. Clin Cancer Res 2007, 13:6257-6266. 10.1158/1078-0432.CCR-07-1247, 17975136.
12. Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T, Holler N, Tschopp J. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 1997, 7:831-836. 10.1016/S1074-7613(00)80401-X, 9430228.
13. Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Immunity 1997, 7:821-830. 10.1016/S1074-7613(00)80400-8, 9430227.
14. Pattje WJ, Melchers LJ, Slagter-Menkema L, Mastik MF, Schrijvers ML, Gibcus JH, Kluin PM, Hoegen-Chouvalova O, van der Laan BF, Roodenburg JL, van der Wal JE, Schuuring E, Langendijk JA. FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck. Histopathology 2013, 63:263-270. 10.1111/his.12174, 23763459.
15. Prapinjumrune C, Morita K, Kuribayashi Y, Hanabata Y, Shi Q, Nakajima Y, Inazawa J, Omura K. DNA amplification and expression of FADD in oral squamous cell carcinoma. J Oral Pathol Med 2009, 39:525-532.
16. Chen G, Bhojani MS, Heaford AC, Chang DC, Laxman B, Thomas DG, Griffin LB, Yu J, Coppola JM, Giordano TJ, Lin L, Adams D, Orringer MB, Ross BD, Beer DG, Rehemtulla A. Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas. Proc Natl Acad Sci U S A 2005, 102:12507-12512. 10.1073/pnas.0500397102, 1194899, 16109772.
17. Katoh M. Comparative genomics on mammalian Fgf3-Fgf4 locus. Int J Oncol 2005, 27:281-285.
18. Duvvuri U, Shiwarski DJ, Xiao D, Bertrand C, Huang X, Edinger RS, Rock JR, Harfe BD, Henson BJ, Kunzelmann K, Schreiber R, Seethala RS, Egloff AM, Chen X, Lui VW, Grandis JR, Gollin SM. TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression. Cancer Res 2012, 72:3270-3281. 10.1158/0008-5472.CAN-12-0475-T, 3694774, 22564524.
19. Caputo A, Caci E, Ferrera L, Pedemonte N, Barsanti C, Sondo E, Pfeffer U, Ravazzolo R, Zegarra-Moran O, Galietta LJ. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science 2008, 322:590-594. 10.1126/science.1163518, 18772398.
20. West RB, Corless CL, Chen X, Rubin BP, Subramanian S, Montgomery K, Zhu S, Ball CA, Nielsen TO, Patel R, Goldblum JR, Brown PO, Heinrich MC, van de Rijn M. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol 2004, 165:107-113. 10.1016/S0002-9440(10)63279-8, 1618538, 15215166.
21. Stanich JE, Gibbons SJ, Eisenman ST, Bardsley MR, Rock JR, Harfe BD, Ordog T, Farrugia G. Ano1 as a regulator of proliferation. Am J Physiol Gastrointest Liver Physiol 2011, 301:G1044-G1051. 10.1152/ajpgi.00196.2011, 3233782, 21940901.
22. Britschgi A, Bill A, Brinkhaus H, Rothwell C, Clay I, Duss S, Rebhan M, Raman P, Guy CT, Wetzel K, George E, Popa MO, Lilley S, Choudhury H, Gosling M, Wang L, Fitzgerald S, Borawski J, Baffoe J, Labow M, Gaither LA, Bentires-Alj M. Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling. Proc Natl Acad Sci U S A 2013, 110:E1026-E1034. 10.1073/pnas.1217072110, 3600458, 23431153.
23. Astro V, Asperti C, Cangi MG, Doglioni C, de Curtis I. Liprin-alpha1 regulates breast cancer cell invasion by affecting cell motility, invadopodia and extracellular matrix degradation. Oncogene 2011, 30:1841-1849. 10.1038/onc.2010.562, 21151172.
24. Shen JC, Unoki M, Ythier D, Duperray A, Varticovski L, Kumamoto K, Pedeux R, Harris CC. Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1. Cancer Res 2007, 67:2552-2558. 10.1158/0008-5472.CAN-06-3870, 2569966, 17363573.
25. Tan KD, Zhu Y, Tan HK, Rajasegaran V, Aggarwal A, Wu J, Wu HY, Hwang J, Lim DT, Soo KC, Tan P. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma. Genes Chromosomes Cancer 2008, 47:353-362. 10.1002/gcc.20539, 18196592.
26. Kim YI, Lee A, Lee BH, Kim SY. Prognostic significance of syndecan-1 expression in cervical cancers. J Gynecol Oncol 2011, 22:161-167. 10.3802/jgo.2011.22.3.161, 3188714, 21998758.
27. Rasamny JJ, Allak A, Krook KA, Jo VY, Policarpio-Nicolas ML, Sumner HM, Moskaluk CA, Frierson HF, Jameson MJ. Cyclin D1 and FADD as biomarkers in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 2012, 146:923-931. 10.1177/0194599811435052, 22323434.
28. Prapinjumrune C, Morita K, Kuribayashi Y, Hanabata Y, Shi Q, Nakajima Y, Inazawa J, Omura K. DNA amplification and expression of FADD in oral squamous cell carcinoma. J Oral Pathol Med 2010, 39:525-532.
29. Wang QR, Yao XQ, Wen G, Fan Q, Li YJ, Fu XQ, Li CK, Sun XG. Apigenin suppresses the growth of colorectal cancer xenografts via phosphorylation and up-regulated FADD expression. Oncol Lett 2011, 2:43-47. 3412520, 22870126.
30. Tvrdik D, Skalova H, Dundr P, Povysil C, Velenska Z, Berkova A, Stanek L, Petruzelka L. Apoptosis - associated genes and their role in predicting responses to neoadjuvant breast cancer treatment. Med Sci Monit 2012, 18:BR60-BR67. 3560664, 22207111.
31. Dancau AM, Wuth L, Waschow M, Holst F, Krohn A, Choschzick M, Terracciano L, Politis S, Kurtz S, Lebeau A, Friedrichs K, Wencke K, Monni O, Simon R. PPFIA1 and CCND1 are frequently coamplified in breast cancer. Genes Chromosomes Cancer 2010, 49:1-8. 10.1002/gcc.20713, 19787783.
32. Sugahara K, Michikawa Y, Ishikawa K, Shoji Y, Iwakawa M, Shibahara T, Imai T. Combination effects of distinct cores in 11q13 amplification region on cervical lymph node metastasis of oral squamous cell carcinoma. Int J Oncol 2011, 39:761-769.